Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Frontera London

- PMLiVE

Multilingual remote conferencing and interpreting platforms in the era of COVID-19

Turning the pharmaceutical language behind vaccine development into engaging, accessible content

- PMLiVE

A day in the life of Becca McConnell a Senior Account Executive

We asked Becca McConnell to give us an insight into her role as Senior Account Executive at OPEN Health.

OPEN Health

- PMLiVE

The flexible salesforce

By John Procter

- PMLiVE

The importance of pharma intelligence in setting brand strategy

Looking at the different approaches that can be leveraged to assess the competition

- PMLiVE

Nearly 16,000 coronavirus cases left out of UK’s daily figures between 25 September and 2 October

PHE chief exec says ‘technical issue’ caused unreported coronavirus cases

- PMLiVE

Moderna CEO says COVID-19 vaccine will be ready for FDA submission in late November

Company will seek emergency use authorisation for experimental vaccine

- PMLiVE

CEPI establishes global network to compare COVID-19 vaccines

Network will include the UK, Canada, the Netherlands, Italy, Bangladesh and India

- PMLiVE

TikTok and diabetes awareness

The video-sharing platform TikTok has been fostering huge numbers of people documenting the day-to-day reality of their health conditions. From comedy snippets about diagnosis to personal reviews of health tech,...

11 London

- PMLiVE

EMA begins rolling review of AZ’s COVID-19 vaccine candidate

Agency has started evaluating data from non-clinical laboratory studies

- PMLiVE

EMA accepts application for bluebird bio’s Lenti-D in CALD

Gene therapy could become a potentially transformative treatment for cerebral adrenoleukodystrophy

AstraZeneca AZ

Japan resumes AZ’s COVID-19 vaccine trial, but US study remains on hold

Trials have also resumed in the UK, India, South Africa and Brazil

Courageous Conversation ep.9: Elon Musk’s Neuralink and the Future of the Computer Brain Interface

Natalie Yeadon, Co-Owner and Managing Director at Impetus Digital, provides insight on Elon Musk's Neuralink and the Future of the Computer Brain Interface.

Impetus Digital

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links